Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand? - Concepedia

Concepedia

Publication | Open Access

Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?

DOI Full Paper Access

26

Citations

28

References

2021

Year

Mojtaba Shafiekhani, Farbod Shahabinezhad, Tahmoores Niknam, Ahmad Tara, Elham Haem, Parviz Mardani, Zahra Zare, Sedigheh Jafarian, Khatereh Mirzad Jahromi, Sara Arabsheybani,

Virology Journal

Abstract

The administration of Remdesivir as an anti-viral and Tocilizumab as an immunomodulatory drug in solid-organ transplant recipients could be promising treatments of choice to manage COVID-19.

References

	Year	Citations

Page 1